1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Global Startup Commercialization Support Program is sponsored by Global Startup Center, South Korea (Operated by Ministry of SMEs & Startups). This initiative targets non-Korean founders who have established business operations inside South Korea. It provides commercialization funding and follow-up support at the Global Startup Center.
This could assist a US moving company startup with initial marketing, product/service advancement, and intellectual property costs in South Korea.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Non-Korean founders who have established business operations inside South Korea. The program selects 15 startups to participate in a 10-month program. Confirm the full requirements in the official notice before applying.
The current listing shows average ₩50 million (maximum ₩80 million) for commercialization (approximately $37,500 - $60,000 USD). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Global Startup Commercialization Support Program is funded by Global Startup Center, South Korea (Operated by Ministry of SMEs & Startups). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The Economic Development Administration's Build to Scale program is level-funded at $50 million for FY2026 across two competitions — the Venture Challenge and the Capital Challenge. Both require a 1:1 match and reward regional coalitions that spent months building a pipeline before the NOFO dropped. Here's how the program actually works and how to be ready when it opens.
Read articleARPA-H's 2026 SBIR/STTR BAA opens seven transformative health topics with $600K Phase I and $3.5M Phase II contracts — non-dilutive, milestone-driven money. The July 10 Solution Summary gate decides who ever gets to pitch. Here's how the ARPA-H model differs from NIH and how small health-tech firms actually get through the funnel.
Read articleNSF 26-510 is the first SBIR/STTR solicitation written under the 2026 reauthorization — $305,000 Phase I awards, a mandatory Project Pitch gate, and a new instrumentation pilot. This is the deep dive on the deadlines, the eligibility math, and how a deep-tech startup should sequence the July 27 window.
Read article